Terms: = Gastric cancer AND KAT6B, DKFZp313G1618, 23522, MYST4, ENSG00000156650, Q8WYB5, querkopf, qkf, MOZ2, MORF, KIAA0383, FLJ90335 AND Prognosis
1 results:
1. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/kat6b axis.
Cheng W; Luan P; Jin X
Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
[TBL] [Abstract] [Full Text] [Related]
